Nkx-6.3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of Nkx-6.3, a homeobox transcription factor that plays a critical role in the regulation of gene expression during the development of various tissues, particularly in the gastrointestinal tract and nervous system. As a transcription factor, Nkx-6.3 binds to specific DNA sequences and modulates the transcription of target genes involved in cellular differentiation, proliferation, and organ development. It is part of the NK homeobox gene family, known for their role in developmental processes. Inhibitors of Nkx-6.3 function by blocking its DNA-binding ability or disrupting its interaction with other transcriptional regulators, leading to altered expression of its downstream target genes.
The development of Nkx-6.3 inhibitors focuses on small molecules that can bind to the DNA-binding domain of the transcription factor, particularly the homeodomain, which is responsible for recognizing and interacting with specific gene promoters. These inhibitors may also interfere with the protein-protein interactions required for Nkx-6.3 to form complexes with co-regulators or other transcription factors, thus preventing its ability to regulate gene expression effectively. Structural studies of Nkx-6.3 and its DNA-binding motifs have provided critical insights into how the transcription factor interacts with DNA, enabling the design of inhibitors that specifically disrupt its function. By inhibiting Nkx-6.3, researchers can explore the broader impact of its role in developmental gene networks and cellular differentiation. These inhibitors are valuable tools for studying transcriptional regulation mechanisms, allowing for deeper insights into how Nkx-6.3 controls gene expression during development and tissue formation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, which can alter gene expression patterns, possibly influencing NKX6-3 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences the Wnt signaling pathway, which is involved in development and could indirectly affect NKX6-3. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-β receptor, potentially influencing developmental pathways related to NKX6-3 function. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
A selective inhibitor for FGFR and VEGFR, which might affect pathways influencing NKX6-3. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting cytoskeletal dynamics, potentially influencing processes relevant to NKX6-3. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
A GSK-3 inhibitor, acting on the Wnt signaling pathway, potentially affecting NKX6-3. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Another GSK-3 inhibitor, similar to BIO, potentially influencing pathways related to NKX6-3 function. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $63.00 $98.00 | 36 | |
A FGFR inhibitor, which could indirectly affect NKX6-3 by modulating growth factor signaling. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
An inhibitor of Wnt production, potentially affecting pathways relevant to NKX6-3 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which might influence cellular processes and pathways relevant to NKX6-3 function. | ||||||